Dapagliflozin DPPIV Inhibitor add-on Study

Mise à jour : Il y a 4 ans
Référence : NCT00984867

Femme et Homme

Extrait

This study aims to investigate how dapagliflozin can control blood sugar in patients with type 2 diabetes when added to existing treatments (sitagliptin alone or in combination with metformin). The effect of dapagliflozin on weight and blood pressure will also be studied.


Critère d'inclusion

  • Type 2 Diabetes


Liens